"Cycle US : Doing Business and Protecting your innovations in US"

19 mai : 2e partie : Patent Eligibility and Enforceability in the U.S

What will we talk about ?

- Evolving patent eligibility standard in the U.S. related to the biotech companies,
- General overview of United States contested proceedings
- Discussion about extraterritorial effects of U.S. patents


Patents are important economic tools for any company irrespective of size. We will be discussing the evolving patent eligibility standard in the United States as it relates to biotech companies in particular. We will also be discussing the new contested proceedings in the United States from the standpoint of a patent owner, as well as the strategic use of contested proceedings to challenge the patentability of patents held by third parties. Finally, we will discuss the extraterritorial effects of U.S. patents.


Robert C. Mattson is a member of the firm’s Management Committee and is head of the firm’s Litigation Practice Group. Mr. Mattson specializes in adversarial proceedings before the district courts of the United States, the U.S. International Trade Commission, and the U.S. Patent and Trademark Office.

Vincent K. Shier, Ph.D., is a partner in the firm’s Chemical Patent Prosecution and Post-Grant Patent practice groups. Dr. Shier’s practice involves patent prosecution, client counseling, and contested proceeding before the U.S. Patent and Trademark Office, with specific emphasis in the fields of chemistry, biochemistry, biotechnology, biomedicine, genetics, molecular biology, and pharmaceuticals.

About Oblon

Companies across the world depend on Oblon, McClelland, Maier & Neustadt to help them establish, leverage and protect their intellectual property assets in the United States and abroad. Headquartered within steps of the United States Patent and Trademark Office (USPTO), with an affiliate office in Tokyo, Japan, Oblon is one of the largest law firms in the United States focusing exclusively in intellectual property law. For more than 40 years, Oblon has provided a full range of intellectual property services to companies based in Japan, France, Germany, Italy, the United States and other areas of the world. As a result, Oblon has obtained more U.S. utility patents than any other firm in the world for over 25 consecutive years and has become an industry leader in contested proceedings. More information visit : www.oblon.com.

Conférences gratuites sur inscription.

Plus d’informations ? patricia.rigou@genopole.fr

31 mars : S’implanter et établir des partenariats en Life Sciences

Focus Philadelphia

Résumé :

Connaissez-vous la Pennsylvanie et son écosystème en Sciences de la Vie ?

La FACC de Pennsylvanie présentera cet environnement (Princeton/New Jersey...) où aura lieu le prochain congrès BIO.

- Vous souhaitez vous y implanter : quelles sont les modalités ? Les coûts ?

- Témoignage d’une entreprise.

Intervenants :

o Blandine Chantepie-Kari, Co-Director, Trade Services French-American Chamber of Commerce, Philadelphia
o Christophe Tusseau, Conseiller en Développement International, Chambre de Commerce et de l’Industrie de l’Essonne